Wilson to Phylogica

STEWART Washer has resigned from the position of chief executive officer of biopharmaceutical company, Phylogica. The company says it has launched an international search for a new CEO to take it from drug discovery into a next phase of drug development. As part of the new strategy, international drug development expert Doug Wilson was appointed to the board. Dr Wilson was a senior vice president for medicine and regulatory affairs for Boehringer Ingelheim in the US and has also overseen multiple drug registration in Europe.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer